{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T23:30:12Z","timestamp":1790206212459,"version":"4.1.0"},"reference-count":46,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T00:00:00Z","timestamp":1526774400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100002738","name":"Assistance Publique - H\u00f4pitaux de Paris","doi-asserted-by":"publisher","award":["CRC Fibrota"],"award-info":[{"award-number":["CRC Fibrota"]}],"id":[{"id":"10.13039\/501100002738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["OBES SURG"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1007\/s11695-018-3308-7","type":"journal-article","created":{"date-parts":[[2018,5,20]],"date-time":"2018-05-20T00:23:19Z","timestamp":1526775799000},"page":"2886-2893","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":30,"title":["Sleeve Gastrectomy in Morbidly Obese HIV Patients: Focus on Anti-retroviral Treatment Absorption After Surgery"],"prefix":"10.1007","volume":"28","author":[{"given":"Chlo\u00e9","family":"Amouyal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marion","family":"Buyse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Lucas-Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00e9borah","family":"Hirt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Genser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Torcivia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Luc","family":"Bouillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Oppert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3104-9769","authenticated-orcid":false,"given":"Judith","family":"Aron-Wisnewsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,5,20]]},"reference":[{"key":"3308_CR1","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/S0140-6736(08)61113-7","volume":"372","author":"Antiretroviral Therapy Cohort Collaboration","year":"2008","unstructured":"Antiretroviral Therapy Cohort Collaboration. Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies. Lancet Lond Engl. 2008;372:293\u20139.","journal-title":"Lancet Lond Engl"},{"key":"3308_CR2","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1089\/aid.2012.0234","volume":"29","author":"W Lakey","year":"2013","unstructured":"Lakey W, Yang L-Y, Yancy W, et al. Short communication: from wasting to obesity: initial antiretroviral therapy and weight gain in HIV-infected persons. AIDS Res Hum Retrovir. 2013;29:435\u201340.","journal-title":"AIDS Res Hum Retrovir"},{"key":"3308_CR3","doi-asserted-by":"publisher","first-page":"e10106","DOI":"10.1371\/journal.pone.0010106","volume":"5","author":"N Crum-Cianflone","year":"2010","unstructured":"Crum-Cianflone N, Roediger MP, Eberly L, et al. Increasing rates of obesity among HIV-infected persons during the HIV epidemic. PLoS One. 2010;5:e10106.","journal-title":"PLoS One"},{"key":"3308_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.2174\/1874613601509010051","volume":"9","author":"DS Nsagha","year":"2015","unstructured":"Nsagha DS, Assob JCN, Njunda AL, et al. Risk factors of cardiovascular diseases in HIV\/AIDS patients on HAART. Open AIDS J. 2015;9:51\u20139.","journal-title":"Open AIDS J"},{"key":"3308_CR5","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.jviscsurg.2014.12.001","volume":"152","author":"G Pourcher","year":"2015","unstructured":"Pourcher G, Costagliola D, Martinez V. Obesity in HIV-infected patients in France: prevalence and surgical treatment options. J Visc Surg. 2015;152:33\u20137.","journal-title":"J Visc Surg"},{"key":"3308_CR6","doi-asserted-by":"publisher","first-page":"2279","DOI":"10.1007\/s11695-017-2666-x","volume":"27","author":"L Angrisani","year":"2017","unstructured":"Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014. Obes Surg. 2017;27:2279\u201389.","journal-title":"Obes Surg"},{"key":"3308_CR7","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1001\/jama.2011.1914","volume":"307","author":"L Sj\u00f6str\u00f6m","year":"2012","unstructured":"Sj\u00f6str\u00f6m L, Peltonen M, Jacobson P, et al. Bariatric surgery and long-term cardiovascular events. JAMA J Am Med Assoc. 2012;307:56\u201365.","journal-title":"JAMA J Am Med Assoc"},{"key":"3308_CR8","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1056\/NEJMoa066254","volume":"357","author":"L Sj\u00f6str\u00f6m","year":"2007","unstructured":"Sj\u00f6str\u00f6m L, Narbro K, Sj\u00f6str\u00f6m CD, et al. Effects of bariatric surgery on mortality in Swedish obese subjects. N Engl J Med. 2007;357:741\u201352.","journal-title":"N Engl J Med"},{"key":"3308_CR9","doi-asserted-by":"publisher","first-page":"2133","DOI":"10.2337\/dc09-9036","volume":"32","author":"JB Buse","year":"2009","unstructured":"Buse JB, Caprio S, Cefalu WT, et al. How do we define cure of diabetes? Diabetes Care. 2009;32:2133\u20135.","journal-title":"Diabetes Care"},{"key":"3308_CR10","doi-asserted-by":"publisher","first-page":"1892","DOI":"10.1007\/s00125-017-4371-7","volume":"60","author":"J Aron-Wisnewsky","year":"2017","unstructured":"Aron-Wisnewsky J, Sokolovska N, Liu Y, et al. The advanced-DiaRem score improves prediction of diabetes remission 1 year post-roux-en-Y gastric bypass. Diabetologia. 2017;60:1892\u2013902.","journal-title":"Diabetologia"},{"key":"3308_CR11","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1001\/jama.2017.20513","volume":"319","author":"O Reges","year":"2018","unstructured":"Reges O, Greenland P, Dicker D, et al. Association of Bariatric Surgery Using Laparoscopic Banding, roux-en-Y gastric bypass, or laparoscopic sleeve gastrectomy vs usual care obesity management with all-cause mortality. JAMA. 2018;319:279\u201390.","journal-title":"JAMA"},{"key":"3308_CR12","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1016\/j.amjsurg.2014.08.002","volume":"208","author":"JD Zellmer","year":"2014","unstructured":"Zellmer JD, Mathiason MA, Kallies KJ, et al. Is laparoscopic sleeve gastrectomy a lower risk bariatric procedure compared with laparoscopic Roux-en-Y gastric bypass? A meta-analysis. Am J Surg. 2014;208:903\u201310. discussion 909-910","journal-title":"Am J Surg"},{"key":"3308_CR13","doi-asserted-by":"publisher","first-page":"1990","DOI":"10.1016\/j.soard.2017.09.514","volume":"13","author":"G Pourcher","year":"2017","unstructured":"Pourcher G, Peytavin G, Schneider L, et al. Bariatric surgery in HIV patients: experience of an obesity reference center in France. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2017;13:1990\u20136.","journal-title":"Surg Obes Relat Dis Off J Am Soc Bariatr Surg."},{"key":"3308_CR14","doi-asserted-by":"publisher","first-page":"1070","DOI":"10.1007\/s11695-017-2996-8","volume":"28","author":"G Sharma","year":"2017","unstructured":"Sharma G, Strong AT, Boules M, Tu C, Szomstein S, Rosenthal R, et al. Comparative outcomes of bariatric surgery in patients with and without human immunodeficiency virus. Obes Surg 2017;28:1070\u201379.","journal-title":"Obes Surg"},{"key":"3308_CR15","first-page":"233","volume":"71","author":"M Alfa-Wali","year":"2016","unstructured":"Alfa-Wali M, Seechurn S, Ayodeji O, et al. Outcomes of bariatric surgery in human immunodeficiency virus positive individuals: a single center experience. Minerva Chir. 2016;71:233\u20138.","journal-title":"Minerva Chir"},{"key":"3308_CR16","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1016\/j.orcp.2016.06.004","volume":"11","author":"L Muzard","year":"2017","unstructured":"Muzard L, Alvarez J-C, Gbedo C, et al. Tenofovir pharmacokinetic after sleeve-gastrectomy in four severely obese patients living with HIV. Obes Res Clin Pract. 2017;11:108\u201313.","journal-title":"Obes Res Clin Pract"},{"key":"3308_CR17","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1089\/apc.2010.0132","volume":"24","author":"H Selke","year":"2010","unstructured":"Selke H, Norris S, Osterholzer D, et al. Bariatric surgery outcomes in HIV-infected subjects: a case series. AIDS Patient Care STDs. 2010;24:545\u201350.","journal-title":"AIDS Patient Care STDs"},{"key":"3308_CR18","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1016\/j.orcp.2015.09.002","volume":"9","author":"S Zivich","year":"2015","unstructured":"Zivich S, Cauterucci M, Allen S, et al. Long-term virologic outcomes following bariatric surgery in patients with HIV. Obes Res Clin Pract. 2015;9:633\u20135.","journal-title":"Obes Res Clin Pract"},{"key":"3308_CR19","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1007\/s11695-017-2865-5","volume":"28","author":"N Panko","year":"2018","unstructured":"Panko N, Dunford G, Lutfi R. HIV infection is not a contraindication to laparoscopic sleeve gastrectomy for morbid obesity. Obes Surg. 2018;28:464\u20138.","journal-title":"Obes Surg"},{"key":"3308_CR20","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1007\/s11695-014-1350-7","volume":"25","author":"M Fysekidis","year":"2015","unstructured":"Fysekidis M, Cohen R, Bekheit M, et al. Sleeve gastrectomy is a safe and efficient procedure in HIV patients with morbid obesity: a case series with results in weight loss, comorbidity evolution, CD4 count, and viral load. Obes Surg. 2015;25:229\u201333.","journal-title":"Obes Surg"},{"key":"3308_CR21","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.soard.2005.02.004","volume":"1","author":"L Flancbaum","year":"2005","unstructured":"Flancbaum L, Drake V, Colarusso T, et al. Initial experience with bariatric surgery in asymptomatic human immunodeficiency virus-infected patients. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2005;1:73\u20136.","journal-title":"Surg Obes Relat Dis Off J Am Soc Bariatr Surg."},{"key":"3308_CR22","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1177\/0956462415571971","volume":"27","author":"F Eddy","year":"2015","unstructured":"Eddy F, Elvin S, Sanmani L. Bariatric surgery: an HIV-positive patient\u2019s successful journey. Int J STD AIDS 2015;27:70\u20131.","journal-title":"Int J STD AIDS"},{"key":"3308_CR23","doi-asserted-by":"publisher","first-page":"637","DOI":"10.1016\/j.soard.2007.08.012","volume":"3","author":"R Fazylov","year":"2007","unstructured":"Fazylov R, Soto E, Merola S. Laparoscopic gastric bypass surgery in human immunodeficiency virus-infected patients. Surg Obes Relat Dis Off J Am Soc Bariatr Surg. 2007;3:637\u20139.","journal-title":"Surg Obes Relat Dis Off J Am Soc Bariatr Surg"},{"key":"3308_CR24","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1177\/1060028014525034","volume":"48","author":"CE MacBrayne","year":"2014","unstructured":"MacBrayne CE, Blum JD, Kiser JJ. Tenofovir, emtricitabine, and darunavir\/ritonavir pharmacokinetics in an HIV-infected patient after Roux-en-Y gastric bypass surgery. Ann Pharmacother. 2014;48:816\u20139.","journal-title":"Ann Pharmacother"},{"key":"3308_CR25","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/0115426503018002131","volume":"18","author":"M Malone","year":"2003","unstructured":"Malone M. Altered drug disposition in obesity and after bariatric surgery. Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr. 2003;18:131\u20135.","journal-title":"Nutr Clin Pract Off Publ Am Soc Parenter Enter Nutr"},{"key":"3308_CR26","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1345\/aph.1Q414","volume":"46","author":"A Edwards","year":"2012","unstructured":"Edwards A, Ensom MHH. Pharmacokinetic effects of bariatric surgery. Ann Pharmacother. 2012;46:130\u20136.","journal-title":"Ann Pharmacother"},{"key":"3308_CR27","doi-asserted-by":"publisher","first-page":"785","DOI":"10.1007\/s11695-015-1803-7","volume":"26","author":"EO Verger","year":"2015","unstructured":"Verger EO, Aron-Wisnewsky J, Dao MC, Kayser BD, Oppert J-M, Bouillot J-L, et al. Micronutrient and protein deficiencies after gastric bypass and sleeve gastrectomy: a 1-year follow-up. Obes Surg 2015;26:785\u201396.","journal-title":"Obes Surg"},{"key":"3308_CR28","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1128\/AAC.48.1.176-182.2004","volume":"48","author":"GJ Yuen","year":"2004","unstructured":"Yuen GJ, Lou Y, Bumgarner NF, et al. Equivalent steady-state pharmacokinetics of lamivudine in plasma and lamivudine triphosphate within cells following administration of lamivudine at 300 milligrams once daily and 150 milligrams twice daily. Antimicrob Agents Chemother. 2004;48:176\u201382.","journal-title":"Antimicrob Agents Chemother"},{"key":"3308_CR29","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1128\/AAC.43.7.1708","volume":"43","author":"LH Wang","year":"1999","unstructured":"Wang LH, Chittick GE, McDowell JA. Single-dose pharmacokinetics and safety of abacavir (1592U89), zidovudine, and lamivudine administered alone and in combination in adults with human immunodeficiency virus infection. Antimicrob Agents Chemother. 1999;43:1708\u201315.","journal-title":"Antimicrob Agents Chemother"},{"key":"3308_CR30","doi-asserted-by":"publisher","first-page":"6782","DOI":"10.1128\/AAC.01099-15","volume":"59","author":"A Curran","year":"2015","unstructured":"Curran A, Mart\u00ed R, L\u00f3pez RM, et al. Darunavir and ritonavir Total and unbound plasmatic concentrations in HIV-HCV-Coinfected patients with hepatic cirrhosis compared to those in HIV-monoinfected patients. Antimicrob Agents Chemother. 2015;59:6782\u201390.","journal-title":"Antimicrob Agents Chemother"},{"key":"3308_CR31","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1177\/0091270007300951","volume":"47","author":"MR Blum","year":"2007","unstructured":"Blum MR, Chittick GE, Begley JA, et al. Steady-state pharmacokinetics of emtricitabine and tenofovir disoproxil fumarate administered alone and in combination in healthy volunteers. J Clin Pharmacol. 2007;47:751\u20139.","journal-title":"J Clin Pharmacol"},{"key":"3308_CR32","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1177\/0091270007300808","volume":"47","author":"J Zong","year":"2007","unstructured":"Zong J, Chittick GE, Wang LH, et al. Pharmacokinetic evaluation of emtricitabine in combination with other nucleoside antivirals in healthy volunteers. J Clin Pharmacol. 2007;47:877\u201389.","journal-title":"J Clin Pharmacol"},{"key":"3308_CR33","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1086\/588794","volume":"47","author":"M Iwamoto","year":"2008","unstructured":"Iwamoto M, Wenning LA, Mistry GC, et al. Atazanavir modestly increases plasma levels of raltegravir in healthy subjects. Clin Infect Dis Off Publ Infect Dis Soc Am. 2008;47:137\u201340.","journal-title":"Clin Infect Dis Off Publ Infect Dis Soc Am"},{"key":"3308_CR34","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1093\/jac\/dkn204","volume":"62","author":"N Hentig von","year":"2008","unstructured":"von Hentig N, Babacan E, Lennemann T, et al. The steady-state pharmacokinetics of atazanavir\/ritonavir in HIV-1-infected adult outpatients is not affected by gender-related co-factors. J Antimicrob Chemother. 2008;62:579\u201382.","journal-title":"J Antimicrob Chemother"},{"key":"3308_CR35","doi-asserted-by":"publisher","first-page":"970","DOI":"10.1177\/0091270007302564","volume":"47","author":"I Ofotokun","year":"2007","unstructured":"Ofotokun I, Chuck SK, Binongo JN, et al. Lopinavir\/ritonavir pharmacokinetic profile: impact of sex and other covariates following a change from twice-daily to once-daily therapy. J Clin Pharmacol. 2007;47:970\u20137.","journal-title":"J Clin Pharmacol"},{"key":"3308_CR36","doi-asserted-by":"publisher","first-page":"1345","DOI":"10.2174\/138920012803341339","volume":"13","author":"RA Sawaya","year":"2012","unstructured":"Sawaya RA, Jaffe J, Friedenberg L, et al. Vitamin, mineral, and drug absorption following bariatric surgery. Curr Drug Metab. 2012;13:1345\u201355.","journal-title":"Curr Drug Metab"},{"key":"3308_CR37","doi-asserted-by":"publisher","first-page":"540","DOI":"10.3945\/ajcn.114.104307","volume":"102","author":"E Mans","year":"2015","unstructured":"Mans E, Serra-Prat M, Palomera E, et al. Sleeve gastrectomy effects on hunger, satiation, and gastrointestinal hormone and motility responses after a liquid meal test. Am J Clin Nutr. 2015;102:540\u20137.","journal-title":"Am J Clin Nutr"},{"key":"3308_CR38","doi-asserted-by":"publisher","first-page":"1018","DOI":"10.1007\/s00464-014-3794-1","volume":"29","author":"VWC Ying","year":"2015","unstructured":"Ying VWC, Kim SHH, Khan KJ, et al. Prophylactic PPI help reduce marginal ulcers after gastric bypass surgery: a systematic review and meta-analysis of cohort studies. Surg Endosc. 2015;29:1018\u201323.","journal-title":"Surg Endosc"},{"key":"3308_CR39","doi-asserted-by":"publisher","first-page":"509","DOI":"10.2165\/11531320-000000000-00000","volume":"49","author":"R Ogawa","year":"2010","unstructured":"Ogawa R, Echizen H. Drug-drug interaction profiles of proton pump inhibitors. Clin Pharmacokinet. 2010;49:509\u201333.","journal-title":"Clin Pharmacokinet"},{"key":"3308_CR40","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1111\/j.1365-2125.2005.02413.x","volume":"60","author":"JE Ray","year":"2005","unstructured":"Ray JE, Marriott D, Bloch MT, et al. Therapeutic drug monitoring of atazanavir: surveillance of pharmacotherapy in the clinic. Br J Clin Pharmacol. 2005;60:291\u20139.","journal-title":"Br J Clin Pharmacol"},{"key":"3308_CR41","first-page":"1","volume":"51","author":"M Dybul","year":"2002","unstructured":"Dybul M, Fauci AS, Bartlett JG, et al. Guidelines for using antiretroviral agents among HIV-infected adults and adolescents recommendations of the Panel on Clinical Practices for Treatment of HIV. MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control. 2002;51:1\u201355.","journal-title":"MMWR Recomm Rep Morb Mortal Wkly Rep Recomm Rep Cent Dis Control"},{"key":"3308_CR42","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1089\/08892220260190290","volume":"18","author":"EP Acosta","year":"2002","unstructured":"Acosta EP, Gerber JG, Adult Pharmacology Committee of the AIDS Clinical Trials Group. Position paper on therapeutic drug monitoring of antiretroviral agents. AIDS Res Hum Retrovir. 2002;18:825\u201334.","journal-title":"AIDS Res Hum Retrovir"},{"issue":"6","key":"3308_CR43","doi-asserted-by":"publisher","first-page":"3020","DOI":"10.1128\/AAC.06407-11","volume":"56","author":"DM Moss","year":"2012","unstructured":"Moss DM, Siccardi M, Murphy M, et al. Divalent metals and pH alter raltegravir disposition in vitro. Antimicrob Agents Chemother. 2012;56(6):3020\u20136.","journal-title":"Antimicrob Agents Chemother"},{"key":"3308_CR44","doi-asserted-by":"publisher","first-page":"818","DOI":"10.1007\/s11695-016-2538-9","volume":"27","author":"R Kassir","year":"2017","unstructured":"Kassir R, Huart E, Tiffet O, et al. Feasibility of bariatric surgery in the HIV-infected patients. Obes Surg. 2017;27:818\u20139.","journal-title":"Obes Surg"},{"key":"3308_CR45","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1590\/S0036-46652015000200002","volume":"57","author":"LR Soares","year":"2015","unstructured":"Soares LR, da Silva DC, Gonsalez CR, et al. Discordance between body mass index and anthropometric measurements among HIV-1-infected patients on antiretroviral therapy and with lipoatrophy\/lipohypertrophy syndrome. Rev Inst Med Trop S\u00e3o Paulo. 2015;57:105\u201310.","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"3308_CR46","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1038\/oby.2009.348","volume":"18","author":"C Ciangura","year":"2010","unstructured":"Ciangura C, Bouillot J-L, Lloret-Linares C, et al. Dynamics of change in total and regional body composition after gastric bypass in obese patients. Obes Silver Spring Md. 2010;18:760\u20135.","journal-title":"Obes Silver Spring Md"}],"container-title":["Obesity Surgery"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11695-018-3308-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-018-3308-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11695-018-3308-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,20]],"date-time":"2019-05-20T23:13:12Z","timestamp":1558393992000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11695-018-3308-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,20]]},"references-count":46,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["3308"],"URL":"https:\/\/doi.org\/10.1007\/s11695-018-3308-7","relation":{},"ISSN":["0960-8923","1708-0428"],"issn-type":[{"value":"0960-8923","type":"print"},{"value":"1708-0428","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,5,20]]},"assertion":[{"value":"20 May 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"The authors declare that they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and\/or national research committee and with the 1964 Helsinki declaration and its later amendments or comparable ethical standards.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Statement"}},{"value":"Informed consent was obtained from all individual participants included in the study.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Informed Consent"}}]}}